back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-27 16:58 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$338,234
+53,688 vol $6.30 each |
160,186 | |
| Filed 2026-03-27 16:56 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$932,456
+148,009 vol $6.30 each |
812,953 | |
| Filed 2026-03-27 16:53 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$129,046
+20,132 vol $6.41 each |
198,810 | |
| Filed 2026-03-27 16:51 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-103,469.76
-23,304 vol $4.44 each |
106,498 | |
| Filed 2026-03-27 16:48 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-51,734.88
-11,652 vol $4.44 each |
0 | |
| Filed 2026-03-23 17:12 Tx date 2026-03-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-549,110.64
-71,592 vol $7.67 each |
664,944 | |
| Filed 2026-03-20 15:29 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,390
+451 vol $5.30 each |
178,678 | |
| Filed 2026-03-20 15:27 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,003
+973 vol $6.17 each |
178,227 | |
| Filed 2025-12-19 14:03 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,787
+536 vol $5.20 each |
177,254 | |
| Filed 2025-12-19 14:01 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,006
+1,162 vol $6.03 each |
176,718 | |
| Filed 2025-09-17 15:38 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,386
+540 vol $4.42 each |
175,556 | |
| Filed 2025-09-17 15:36 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,006
+940 vol $6.39 each |
175,016 | |
| Filed 2025-07-11 16:30 Tx date 2025-04-03 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-649,088.10
-83,970 vol $7.73 each |
736,536 | |
| Filed 2025-06-18 16:21 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,730
+555 vol $4.92 each |
174,076 | |
| Filed 2025-06-18 16:19 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,952
+1,151 vol $6.04 each |
173,521 | |
| Filed 2025-04-04 18:40 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$66,531
+10,783 vol $6.17 each |
172,370 | |
| Filed 2025-04-04 18:37 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-96,249.54
-18,474 vol $5.21 each |
129,802 | |
| Filed 2025-04-04 18:34 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-48,124.77
-9,237 vol $5.21 each |
11,652 | |
| Filed 2025-03-29 16:18 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$325,112
+52,353 vol $6.21 each |
148,276 | |
| Filed 2025-03-29 16:17 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$997,040
+160,554 vol $6.21 each |
820,506 |